$AKCA #Stocks #StockMarket #AkceaTherapeutics released Q1 EPS on https://t.co/savSNTKlN1: Income faded from preceding quarter from $1.67 per share, Revenue deteriorated by -94.207 % from $277 millions. https://t.co/P9cxFEAcRR